Meng Haojie, Bigambo Francis Manyori, Gu Wei, Wang Xu, Li Yang
Department of Children Health Care, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Clinical Medical Research Center, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Front Endocrinol (Lausanne). 2024 Dec 9;15:1498788. doi: 10.3389/fendo.2024.1498788. eCollection 2024.
Thyroid hormones (THs) are essential for brain development. Numerous studies have identified significant links between thyroid dysfunction and cognitive function. However, research on the significance and necessity of thyroid function tests in diagnosis of neurological disorders is limited and subject to controversy.
Our study employed a combination of meta-analysis and case-control design. For the meta-analysis, we conducted a systematic search of online databases for studies that compared thyroid function tests in children with neurological disorders to controls. In our case-control study, we recruited a total of 11836 children, comprising 7035 cases and 4801 healthy controls. Wilcoxon Rank Sum Test was used to determine characteristics of thyroid function between the cases and healthy controls. In order to exclude the false discovery rate (FDR), the Benjamini-Hochberg (BH) procedure is applied.
A total of 12 relevant literature sources were included in the meta-analysis. Compared with controls, free thyroxine (FT4) levels were significantly decreased in neurological disorders in meta-analysis (MD = -0.29, 95% CI: -0.50 to -0.09), whereas thyroid-stimulating hormone (TSH) levels showed no significant difference (MD = -0.07, 95% CI: -0.36 to 0.21). In our case-control study, levels of free thyroxine (FT4), total triiodothyronine (TT3), total thyroxine (TT4), and anti-thyroglobulin antibodies (TG-Ab) were notably reduced among individuals with neurological disorders, compared with healthy controls (<0.001, 0.001, =0.036, =0.006). However, thyroid-stimulating hormone (TSH) levels did not show any statistically significant differences among the cases and controls.
Our research demonstrates that, in comparison to controls, children with neurological disorders exhibited a significant decrease in FT4 levels, while TSH levels remained unchanged. This finding provides a reference for potential serum marker of neurological disorders in children. Replication in future studies with the assessment of THs is needed to determine whether thyroid function should be included as a routine screening in these children.
甲状腺激素(THs)对大脑发育至关重要。众多研究已确定甲状腺功能障碍与认知功能之间存在显著关联。然而,关于甲状腺功能测试在神经系统疾病诊断中的意义和必要性的研究有限且存在争议。
我们的研究采用了荟萃分析和病例对照设计相结合的方法。对于荟萃分析,我们对在线数据库进行了系统检索,以查找比较神经系统疾病患儿与对照组甲状腺功能测试的研究。在我们的病例对照研究中,我们共招募了11836名儿童,其中包括7035例病例和4801名健康对照。采用Wilcoxon秩和检验来确定病例组和健康对照组之间甲状腺功能的特征。为了排除错误发现率(FDR),应用了Benjamini-Hochberg(BH)程序。
荟萃分析共纳入12篇相关文献来源。与对照组相比,荟萃分析中神经系统疾病患儿的游离甲状腺素(FT4)水平显著降低(MD = -0.29,95%CI:-0.50至-0.09),而促甲状腺激素(TSH)水平无显著差异(MD = -0.07,95%CI:-0.36至0.21)。在我们的病例对照研究中,与健康对照组相比,神经系统疾病患儿的游离甲状腺素(FT4)、总三碘甲状腺原氨酸(TT3)、总甲状腺素(TT4)和抗甲状腺球蛋白抗体(TG-Ab)水平显著降低(<0.001,0.001,=0.036,=0.006)。然而,促甲状腺激素(TSH)水平在病例组和对照组之间未显示出任何统计学显著差异。
我们的研究表明,与对照组相比,神经系统疾病患儿的FT4水平显著降低,而TSH水平保持不变。这一发现为儿童神经系统疾病潜在的血清标志物提供了参考。未来需要通过对THs的评估进行重复研究,以确定是否应将甲状腺功能纳入这些儿童的常规筛查。